These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Aspirin may cut heart disease deaths in women with heart disease. Cardiovasc J S Afr; 2006; 17(1):37. PubMed ID: 16547561 [No Abstract] [Full Text] [Related]
23. Aspirin and its rivals. As your options increase, your choices get harder. Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131 [No Abstract] [Full Text] [Related]
24. [Before polyp removal. To stop or not to stop ASA?]. Füessl HS MMW Fortschr Med; 2003 Sep; 145(39):10. PubMed ID: 14649063 [No Abstract] [Full Text] [Related]
25. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Maree AO; Fitzgerald DJ Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618 [No Abstract] [Full Text] [Related]
26. [Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?]. Flipo RM Presse Med; 2006 Sep; 35(9 Spec No 1):1S53-60. PubMed ID: 17078596 [TBL] [Abstract][Full Text] [Related]
27. NSAID-induced gastrointestinal and cardiovascular injury. Ng SC; Chan FK Curr Opin Gastroenterol; 2010 Nov; 26(6):611-7. PubMed ID: 20948372 [TBL] [Abstract][Full Text] [Related]
28. Coxibs and cardiovascular risk. Allen MJ; McLean-Veysey P; Fleming I CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098 [No Abstract] [Full Text] [Related]
29. Aspirin: new cardiovascular uses for an old drug. Patrono C Am J Med; 2001 Jan; 110(1A):62S-65S. PubMed ID: 11166001 [TBL] [Abstract][Full Text] [Related]
30. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events. Rodondi N; Bauer DC Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713 [No Abstract] [Full Text] [Related]
32. Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease. Brass EP; Hiatt WR Circulation; 2017 Aug; 136(9):785-786. PubMed ID: 28847795 [No Abstract] [Full Text] [Related]
33. Hemoptysis under diclofenac and antiplatelet doses of aspirin. Yiannakopoulou EC Pharmacology; 2011; 87(1-2):1-4. PubMed ID: 21150234 [TBL] [Abstract][Full Text] [Related]
34. Cardioprotective effects of aspirin compromised by other NSAIDs. Gottlieb S BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958094 [No Abstract] [Full Text] [Related]
35. What price pain relief? Hochman JS; Shah NR Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335 [No Abstract] [Full Text] [Related]
36. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials. Berger JS; Lala A; Krantz MJ; Baker GS; Hiatt WR Am Heart J; 2011 Jul; 162(1):115-24.e2. PubMed ID: 21742097 [TBL] [Abstract][Full Text] [Related]
37. Aspirin for the prevention of cardiovascular disease. Lin KW Am Fam Physician; 2011 Jun; 83(12):1469-70. PubMed ID: 21671548 [No Abstract] [Full Text] [Related]
38. Bleeding risk with aspirin must be balanced against benefit. Harv Heart Lett; 2012 Aug; 22(12):8. PubMed ID: 23025025 [No Abstract] [Full Text] [Related]
39. Uncovering the benefits of aspirin. Johns Hopkins Med Lett Health After 50; 2007 Feb; 18(12):3. PubMed ID: 17340747 [No Abstract] [Full Text] [Related]
40. Letter by Cen regarding article, "Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas". Cen YY Circulation; 2007 Mar; 115(12):e348; author reply e349. PubMed ID: 17389275 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]